...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

Give it a rest. The science doesn't operate independent of the Company. Did the science bring on Eversana or finance the Company after the science failed us in trials numerous times? The CEO takes responsibilty as he should but do you think he designed the trials?

This Company could have folded at least twice if we didn't have this CEO imo. Do you actually think that there are no partnership discussions going on? Seems we always have money when we need it.

The move with Zenith was also a great management decision.

We are all frustrated that we haven't been successful yet but its easy to sit back and be an armchair CEO.

 

Share
New Message
Please login to post a reply